News
5d
Zacks.com on MSNHere's What to Expect From Pfizer's Non-Oncology Drugs in Q2 EarningsPFE's non-oncology portfolio draws focus in Q2, with strength in Vyndaqel and Nurtec offsetting some vaccine softness.
Nurtec ODT is used to treat and prevent migraines in adults. The claims resolved are allegations only, and there has been no determination of liability, the DOJ said. The DOJ contends the alleged ...
Nurtec ODT, also known as Rimegepant, was approved for treating acute migraine in February 2020 and its approval was extended to preventing episodic migraine in June 2021. The drug was promoted by ...
The settlement resolves allegations that Biohaven paid improper remuneration, including speaker honoraria and high-end restaurant meals, to physicians and other healthcare professionals to promote ...
Pfizer (PFE) has agreed to pay nearly $60M to resolve allegations that its Biohaven unit paid kickbacks to induce prescriptions for its migraine drug Nurtec ODT. Read more here.
Pfizer has agreed to pay $59,746,277.54, plus interest, ... lavish meals, and honoraria payments to health care providers to encourage them to prescribe Nurtec ODT (Nurtec), ...
Pfizer Inc. Chief Executive Officer Albert Bourla said he’ll do “whatever it takes” to keep profits growing, ... Nurtec ODT for migraine and Xtandi for prostate cancer.
Nurtec ODT, also known as Rimegepant, was approved for treating acute migraine in February 2020 and its approval was extended to preventing episodic migraine in June 2021.
The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks over a migraine drug. ... Nurtec ODT, also known as Rimegepant, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results